Breast Preservation Therapy in Stage I and II Carcinoma: Factors Affecting Outcome

Authors

  • Carlos A. Perez Radiation Oncology Center Mallinckrodt Institute of Radiology Kadiology Washington University School of Medicine

Abstract

Records were reviewed of 511 patients with 519 histologically confirmed carcinomas of the breast treated with wide local excision of tumor and irradiation to the breast (4600 to 5000 cGy in 5 weeks) and, in 109 patients, to regional lymphatics. In 271 patients with T1 and 98 with T2 tumor, boost to primary tumor site (1000-2000 cGy) was delivered using electrons (9-12 MeV); in 72 patients with T1 and 34 with T2 tumors, 192Ir implant was performed. Pathologic staging was T1 in 373 and T2 in 146 lesions (1988 AJC). Sixty-seven patients (18%) with T1 and 46 (32%) with T2 tumors had microscopically positive axillary lymph nodes.

 

Actuarial breast relapse rates at 5 years were 5% in T1 and 10% in T2 tumors and at 10 years 12% and 18%, respectively. Lymph node recurrenses were noted in 1% of T1 and 5% of T2 tumors. Distant metastases were detected in 5% of T1 and 22% of T2 tumors. Five-year actuarial breast relapse rates were 10% in T1 tumors and 18% in T2 (p = 0.04). Differences in 5- years breast relapse for patients with extensive intraductal component (EIC) were not statistically signifi-cant ( 7% in T1 tumors with EIC and 4% without it; 14% in T2 tumors with EIC and 7% without it). There was minimal correlation of irradiation dose to primary tumor

with breast relapse (in T1 from 2% to 7% and in T2 from 7% to 9% with doses >5500 cGy in contrast to 20% with 5000 to 5500 cGy). No correlation was noted with either type of boost (electrons or interstitial brachytherapy). Desease-free survival for patients with T1 tumors was 87% at 5 years and 82% at 10 years; for patients with T2 tumors, it was 75% at 5 years and 70% at 10 years.

 

Excellent/good cosmetic results were obtained in 78% of the patients. No difference was observed between the group treated with electrons or 192 Ir implant to the boost area.

 

Better understanding of prognostic factors and refinement of treatment techniques will enhance the results of breast conservation therapy.

Downloads

Download data is not yet available.

References

1 - Blichert-Toft M: A Danish randomized trial comparing breast preservation

with mastectomy in mammary carcinoma.

Proceedings of the NIH Consensus Development Conference Early Stage Breast

Cancer, June 1990, pp 28-31.

2 - Fisher B. Redmond C, Poisson R,

et al: Eight-year results of a randomized

clinical trial comparing total mastectomy

and lumpectomy with or without irradiation in the tratment of breast cancer. N

Engl J Med. 320:822-828, 1989.

3 - Glatstein E. Straus K. Lichter A.

Lippman M, Danforth D, Swain S, Cowan

K, de Moss E, McDonald H, d'Angelo T,

Steinberg S, Merino M, Bader J, Findlay P,

Rosenberg S: Results of the NCI early

breast cancer trial. Proceedings of the

NIH Consensus Development Conference

Early Stage Breast Cancer, June 1990, pp

32-33.

4 - Ryoo ME, Kagan AR, Wollin M,

Tome MA, Tedeschi AA, Rao AR, Hintz BL,

Kuruvilla AM, Nussbaum H, Streeter OE,

Jabola BR, Miller MJ: Prognostic factors

for recurrence and cosmesis in 393 patients after radiation therapy for early

mammary carcinoma. Radiology 172:555-

559, 1989.

5 - Van Dongen JA: Randomized clinical trial to assess the value of breast

conserving therapy in stage I and II breast

cancer: EORTC trial 10801. Proceedings

of the NIH Consensus Development Conference Early Stage Breast Cancer, June

1990, pp. 25-27.

6 - Veronesi U, Banfi A, DelVecchio M,

Saccozzi R, Clement C, Greco M, Luini A,

Maruloini E, Muscolina G, Rilke F, Sacchini

V, Salvatori B, Zecchini A, Zucali R: Comparison of Halsted mastectomy with

quadrantectomy, axillary dissection and

radiotherapy in early breast cancer: Longterm results. Eur J Cancer Clin Oncol.

22:1085-1089, 1986.

7 - Beadle GF, Harris JR, Silver B,

Botnick L, Hellman S: Cosmetic results

following primary radiation therapy for

early breast cancer. Cancer. 54:2911-

2918, 1984

8 - Kuske RR, Garcia DM, Perez CA,

Philpott GW, Lyss AP, Movsas T, Fineberg

B: Cosmesis after breast conservation

therapy: Surgical radiotherapeutic, chemotherapeutic, host, and tumor factors

influencing results. Int J Radiat Oncol Biol

Phis. (submitted for publication).

9 - Rose MA Olivotto I, Cady B, et al:

Conservative surgery and radiation

therapy for early breast cancer: Longterm cosmetic results. Ann urg. 124:153-

157, 1989.

10 - Boyages J, Recht A, Connolly SJ,

Gelman R, Kooy H, Love S, Osteen RT,

Cady B, Silver B, Harris JR: Early breast

cancer: Predictors of breast recurrencе

for patients treated with conservative

surgery and radiation therapy. Radiother

Oncol. 19:29-41, 1990.

11 - Danoff B. Goodman RL: Identification of subset of patients with early

breast cancer in whom conservative surgery and radiation is contraindicated. Int

J Radiat Oncol Biol Phys. 11:104, 1985.

12 - Eberlein TJ, Connolly JL, Schitt

SJ, Recht A, Osteen RT, Harris JR: Predictors of local recurrence following conservative breast surgery and radiation

therapy: The influence of tumor size. Arch

Surg. 125:771-777, 1990.

13 - Fisher ER, Sass R, Fisher B.

Gregory R, Brown R, Wickerham L, NSABP

Investigators: Pathologic findings from

the National Surgical Adjuvant Breast

Project (Protocol 6). II. Relation of local

breast recurrence to multicentricitty. Cancer 57:1717-1724, 1986.

14- Haffty BG, Fischer D, Rose M,

Beinfield M, Mckhann C: Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A

cautious interpretation of the data. J Clin

Oncol. 9:997-1003, 1991.

15 - Kurtz JM, Jacquemier J, Amalric

R, Brandone H, Ayme Y, Hans D, Bressac

C, Roth J, Spitalier J-M: Risk factors for

breast recurrence in premenopausal and

postmenopausal patients with ductal cancers treated by conservation therapy.

Cancer. 65:1867-1878, 1990.

16 - Schitt SJ, Connoly JL, Recht A,

Silver B, Harris JR: Breast relapse following primary radiation therapy for early

breast cancer. II. Detection of pathologic

features and prognostic significance. Int

J Radiat Oncol Biol Phys. 11:1277-1284,

1985.

17 - Zafrani B, Vielh P, Fourquet A,

Mosseri V, Durand JC, Salmon RJ, Vilcoq

JR: Conservative treatment of early breast

cancer: Prognostic value of ductal in situ

component and other pathologic variables on local control and survival. Eur J

Cancer Clin Concol. 25:1645-1650, 1989.

18- Kurtz JM, Amalric R, Brandone H,

Qyme Y, Spitalier J-M: How important is

adequate radiotherapy for the long-term

results of breast-conserving treatment?

Radiother Oncol. 20:84-90, 1991.

19 - Recht A, Silver B. Schnitt S.

Connelly J, Hellman S, Harris JR: Breast

relapse following primary radiation

therapy for early breast cancer. I - Classification, frequency and salvage. Int J

Radiat Oncol Biol Phys 11:1271-1276,

1985.

20 - Haffty BG, Goldberg NB, Fisher

D,, Mckhann C, Beinfield M, Weissberg

JB, Carter D, Geral W: Conservative surgery and radiation therapy in breast carcinoma: Local recurrence and prognostic

implications. int J Radiat Oncol Biol Phys.

17:727-732, 1989.

21 - Hallahan De, Michel Ag, Halpern

HJ, Awan AM, Desser R, Bitran J, Recant

W, Wyman B, Spelbring DR,

Weichselbaum RR: Breast conservating

surgery and definitive irradiation for early

stage breast cancer. Int J Radiat Oncol

Biol Phys. 17:1211-1216, 1989.

22 - Rutqvist LE, Cedermark B, Glas U,

Johansson H, Rotstein S, Skoog L, Somell

A, Theve T, Askergren J, Friberg S,

Bergstrom J, Blomstedt B, Rat L,

Silfversward C, Einhorn J: Radiotherapy,

chemotherapy, and taxoxifen as adjuncts

to surgery in early breast cancer: A summary of three ramdomized trials. int J

Radiat Oncol Biol Phys. 15:629, 1989.

23 - Beahrs OH, Henson DE, Hutter

RVP, Myers MM (eds): Manual for staging of cancer, 3rd ed. Philadelphia, JB

Lippincott, 1988.

24 - Perez CA, Garcia DM, Kuske RR,

Halverson KJ, Coke C, McBurney L,

Myerson R, Philpott G, Levy J, Simpson

JR, Tucker G, Vest M, Lockett MA, Rush

C: Organ preservation therapy in stage T1

and T2 carcinoma of the breast. Front

Radiat Ther Oncol. (in press).

25 - Dixon WJ: BMDP Statistical Software. Los Angeles, University of California Press, 1982.

26 - Dixon WJ: News for 1987 release

of BMDP statistical software. Los Angeles, University of California press, 1986.

27 - Cutler SJ. Ederer F: Maximum

utilization of the life table method in analyzing survival. J Chron Dis. 8:699-713,

1958.

28 - Miller R: Survival Analysis. New

York, John Willey, 1981.

29 - Tarone R, Ware J: On distribution

free tests for equality of survival distributions. Biometrika. 64:156-160, 1977.

30 - Tarone R: Tests for trend in life

table analysis. Biometrika.

31 - Perez CA, Garcia DM. Kuske RR,

levitt SH: Breast: Stage T, and T2 tumors;

In Perez CA, Brady LW (eds): Principlesand practice of radiation oncology, 2nd

ed. Philadelphia, JB Lippincott, 1992.

32 - Harris JR, Connolly JL, Schnitt

SJ, Cady B, Love S, Osteen RT, Patterson

WB, Shirley R, Hellman S, Cohen RB,

Silen W: The use of pathologic features in

selecting the extent of surgical resection

necessary for breast cancer patients

treated by primary radiation therapy. Ann

Surg. 210:164-169, 1985.

33 - Sarrazin D, Le MG, Arriagada R,

Contesso G, Fontaine F, Spielmann M,

Rochard F, le Chevalier TH, Lacour J: Tenyear results of a randomized trial comparing a conservative treatment to

mastectomy in early breast cancer.

Radiother Oncol 14:177, 1989.

34 - Calle R, Pilleron J, Schlienger P,

Vilcoq JR: Conservative management of

operable breast cancer: Ten years' experience at the Foundation Curie. Cancer.

42:2045-2053, 1978.

35-Cedermark B,Askergren J, Alveryd

A, et al: Breast-conserving treatment for

breast cancer in Stockholm, Sweden, 1977

to 19881. Cancer. 53:1253-1255, 1984.

36- Clark RM, Wilkinson RH, Mahoney

LJ, Reid JG, MacDonald WD: Breast cancer: A 21 year experience with conservative surgery and radiation. Int J Radiat

Oncol Biol Phys. 8:967-975, 1982.

37 Clarke DH, Le MG, Sarrazin D,

Lacombe MJ, Fountaine F, Travagly J-P,

May-Levin F, Contesso G, Arriagada R:

Analysis of local-regional relapses in patients with early breast cancers treated by

excision and radiotherapy: Experience of

the Institut Gustave-Roussy. int J Radiat

Oncol Biol Phys. 11:137-145, 1985.

38 - Dubois JB, Gary-Bobo J, F

Pourquier H, Pujol H: Tumorectomy and

radiotherapy in early breast cancer: A

report on 392 patients. Int J Radiat Oncol

Biol Phys. 15:1275-1282, 1988.

39 - Fowble BL, Solin LJ, Schultz DJ,

Goodman RL: Ten year results of conservative surgery and irradiation for stage I

and II breast cancer. Int J Radiat Oncol

Biol Phys. 21:269-277, 1991.

40 - Sarrazin D, JA Arriagada R,

Behamou S, Benhamou E, Lasser P,

Fontaine F, Travagly JR, Spielmann M, le

Chevalier T, Contesso G: Conservative

management of breast cancer. Br J Surg.

77:604-606, 1986.

41 - Bartelink H, Borger JH, van Dogen

JA, et al: The impact of tumor size and

histology on local control after breastconserving therapy. Radiother Oncol.

11:297-303, 1988.

42 - Fisher B, Redmond C, Dimirov

NV, Bowman D, Legault-Poisson S,

Wicherham L, Wolmark N, Fisher E,

Margolese R, Sutehrland C, Glass A, Foster R, Caplan R: A randomized clinical trial

evaluating sequential methotrexate and

fluorouracil in the treatment of patients

with node-negative breast cancer who

have estrogen-receptor-negative tumors.

N Engl J Med. 320:473-478, 1989.

43 - Veronesi U, Salvador B, Luini A,

Banfi A, Zucali R, Del Vecchio M, Saccazzi

R. Beretta E, Boracchi P, Farante G,

Galimberti V. Mezzanotte G. Sacchini V,

Tana S, Marubini E: Conservative treatment of early breast cancer: Long-term

results of 1232 cases treated with

quadrantectomy, axillary dissection and

radiotherapy. Ann Surg. 211:250-259,

1990.

44-NIH Consensus Conference: Treatment of early-stage breast cancer. JAMA.

265:391-395, 1991.

45 - Montague ED: Conservation surgery and radiation therapy in the treatment of operable breast cancer. Cancer.

53:700-704, 1984.

46 - Calle R, Volcoq JR, Zafrani B,

Vielh P, Fourquet A: Local control and

survival of breast cancer treatment by

limited surgery followed by irradiation.

Int J Radiat Oncol Biol Phys. 12:873-878,

1986.

47 - Delouche G, Bachelot F, Premont

M, Kurtz JM: Conservation treatment of

early breast cancer: Long-term results

and complications. Int J Radiat Oncol Biol

Phys. 13:29-34, 1987.

48- Van Limbergen E, Van den Bogaert

W, van der Schueren E, Rijnders A: Tumor

excision and radiotherapy as primary treatment of breast cancer: Analysis of patients and treatment parameters and local

control. Radiother Oncol. 8:1-9, 1987.

49 - Fisher B, Anderson S, Fisher ER,

Redmond C, Wickerham DL, Wolmark N,

Mamounas EP, Deutsch M, Margolese R:

Significance of ipsilateral breast tumour

recurrence after lumpectomy. Lancet.

338-327-331, 1991.

50 - Kurtz JM, Spitalier JM, Amalric R:

Late breast recurrence after lumpectomy

and irradiation. Int J Radiat Oncol Biol

Phys. 9:1191-1194, 1983.

51 - Schnitt SJ, Connolly JL, Khettry

U, Mazoujian G, Brenner M, Silver B,

Recht A, Beadle G, Harris JR: Pathologic

findings on re-excision of the primary site

in breast cancer patients considered for

treatment by primary radiation therapy.

Cancer. 59:675-681, 1987.

52 - Solin LJ. Fowble BL, Schultz DJ,

Goodman RL: The significance of the

pathology margins of the tumor excision

on the outcome of patients treated with

definitive irradiation for early stage breast

cancer. Int J Radiat Oncol Biol Phys.

21:279-287, 1991.

53 - Kurtz JM, Jacquemier J, Amalric

R, Brandone H, Ayme Y, Hans D, Bressac

C, Spitalier J: Why are local recurrences

after breast conserving therapy more frequent in young patients? J Clin Oncol.

8:591, 1990.

54- Fourquet A, Campana F, Zafrani B,

Mosseri V, Vielh P, Durand J-C, Vilcoq JR:

Prognostic factors of breast recurrence

in the conservative management of early

breast cancer: A 25-year follow-up. Int J

Radiat Oncol Biol Phys. 17:719-725, 1989.

55 - Olivotto IA, Rose MA, Osteen RT,

Love S, Cady B, Recht A, Harris JR: Late

cosmetic outcome after conservative surgery and radiotherapy: Analysis of causes

of cosmetic failure. Int J Radiat Oncol Biol

Phys. 17:747-753, 1989.

56 - Ray GR, Fish VJ: Biopsy and

definitive radiation therapy in stage I and

Il adenocarcinoma of the female breast:

Analysis of cosmesis and the role of

electron beam supplementation. Int J

Radiat Oncol Biol Phys. 9:813-818, 1983.

57 - Recht A, Come SE, Gelman RS,

Goldstein M, Tishler S, Gore SM, Abner

AL, Vicini FA, Silver B, Connoly JL, Schnitt

SJ, Coleman CN, Harris JR: Integration of

conservative surgery, radiotherapy, and

chemotherapy for the treatment of earlystage, node-positive breast cancer: Sequencing, timing, and outcome. J Clin

Oncol. 9:1662-1667, 1991.

58 - Fowble B, Goodman RL, Glick JH,

Rosato EF: Breast cancer treatment: A

comprehensive guide to management.

St. Louis, Mosby Year Book, 1991.

59 - Harris JR, Hellman S, Henderson

IC, Kinne DW: Breast Diseases, 2nd ed.

Philadelphia, JB Lippincott, 1991.

60 - Dewar JA, Sarrazin D, Benhamou

E, et al: Management of the axilla in

conservatively treated breast cancer: 592

patients treated at Institu GustaveRoussy. Int J Radiat Oncol Biol Phys.

13:475-481, 1987.

61 - Fowble B, Solin LJ Schultz DJ,

Goodman RL: Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and

radiation for early breast cancer. Int J

Radiat Oncol Biol Phys. 17:703-710, 1989.

Downloads

Published

2026-07-21

How to Cite

Perez, C. A. (2026). Breast Preservation Therapy in Stage I and II Carcinoma: Factors Affecting Outcome. Mastology, 2(3). Retrieved from https://mastology.org/journal/article/view/1943

Issue

Section

Original Articles